published paper


Scientific Publications of Members of the Society

 

  • Zubaidi AM, Al-Saud NH, Al-Qahtani XA, Shaik SA, Abdulla MH, Al-Khayal KA, Al-Obeed OA.  Saudi Med J. 2012 Jun; 33(6):627-33. Bowel function and its associated variables in Saudi adults. A population based study. Saudi Med J. 2012 Jun; 33(6):627-33.
  • Siraj AK, Khalak HG, Sultana M, Al-Rasheed M, Bavi P, Al-Sanea N, Al-Dayel F, Uddin S, Alkuraya FS, Al-Kuraya KS. Colorectal cancer risk is not associated with increased levels of homozygosity in Saudi Arabia. Genet Med. 2012 Apr 5. [Epub ahead of print].
  • Alsanea N. The future of health care delivery and the experience of a tertiary care center in Saudi Arabia. Ann Saudi Med. 2012 Jan;32(2):117-20.
  • Hibbert D, Al-Sanea NA, Balens JA. Perspectives on specialist nursing in saudi arabia: a national model for success. Ann Saudi Med. 2012 Jan;32(1):78-85.
  • Uddin S, Hussain AR, Ahmed M, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Bavi P, Al-Kuraya KS. Coexpression of activated c-Met and death receptor 5 predicts better survival in colorectal carcinoma. Am J Pathol. 2011 Dec;179(6):3032-44. Epub 2011 Oct.
  • Abu-Rafea B, Vilos GA, Al-Obeed O, AlSheikh A, Vilos AG, Al-Mandeel H. Monopolar electrosurgery through single-port laparoscopy: a potential hidden hazard for bowel burns J Minim Invasive Gynecol. 2011 Nov-Dec;18(6):734-40.
  • Bavi P, Abubaker J, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Uddin S, Siraj AK, Al-Kuraya KSClinico-pathological significance of TNF alpha-induced protein3 (TNFAIP3) in Middle Eastern colorectal carcinoma. Clin Epigenetics. 2011 Aug; vol. 2(2) pp. 417-8.
  • Bavi P, Uddin S, Ahmed M, Jehan Z, Bu R, Abubaker J, Sultana M, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Prabhakaran S, Hussain AR, Al-Kuraya KS. Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma.Am J Pathol. 2011 May; 178(5):2109-20.
  • El-Haddad M, Ahmed RS, Al-Suhaibany A, Al-Hazza M, Al-Sanae N, Al-Jabbar AA, Hamoud S, Ashaary L, Bazerbashy S, Balaraj K. Anal canal carcinoma treatment results: The experience of a single institution. Ann Saudi Med. 2011 Mar-Apri, 31(2):158-62.
  • Uddin S, Ahmed M, Hussain A, Abubaker J, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Jehan Z, Bavi P, Siraj AK, Al-Kuraya KS.Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy. Am J Pathol. 2011 Feb;178(2):537-47.
  • Zubaidi AM. Artificial bowel sphincters for fecal incontinence. Are they a solution?  Saudi Med J. 2010 Sep; 31(9):965-73. Review.
  • Alsanea N, Alabbad S. Use of the endostapler for the treatment of non-healing sinus secondary to a dehisced colorectal anastomosis.Tech Coloproctol. 2010 Sep;14(3):249-51.
  • Bavi P, Prabhakaran SE, Abubaker J, Qadri Z, George T, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Hussain AR, Uddin S, Al-Kuraya KS. Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations. Mol Cancer. 2010 Jul 30; 9:203.
  • Abubaker J, Bavi P, Al-Haqawi W, Sultana M, Al-Harbi S, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Uddin S, Al-Kuraya KS. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma. J Pathol. 219(4):435-45, 2009 Dec.
  • Jehan Z, Bavi P, Sultana M, Abubaker J, Bu R, Hussain A, Alsbeih G, AL-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, AL-Dayel F, Uddin S, Al-Kuraya KS. Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer. J Pathol. 219(3):337-46, 2009 Nov.
  • Zubaidi A, Al-Obeed O. Anal fistula plug in high fistula-in-ano: an early Saudi experience.  Dis Colon Rectum. 2009 Sep; 52(9):1584-8.
  • Uddin S, Bavi PP, Hussain AR, Alsbeih G, AL-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Ahmed M, Al-Kuraya KS. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication. Carcinogenesis. 30(11):1832-40, 2009 Nov.
  • Uddin S, Hussain AR, Ahmed M, Abubaker J, AL-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Bavi P, AL-Kuraya KS. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target. Am J Gastroenterol. 104(7):1790-801, 2009 Nov.
  • Zubaidi A. Multiple primary cancers of the colon, rectum, and the thyroid gland.  Saudi J Gastroenterol. 2008 Oct; 14(4):202-5.
  • Al-Johar D, Shinwari N, Arif J, Al-Sanea N, Jabbar AA, el-Sayed R, Mashhour A, Billedo G, El-Dough I, Al-Saleh I. Role of Nigella sativa and a number of its antioxidant constituents towards azoxymethane-induced gentoxic effects and colon cancer in rats. Phytother Res. 22(10):1311-23, 2008 Oct
  • Bazarbashi S. El-Bassiouni M. Abdelsalam M. Soudy H. Sanea NA. Jabbar AA. Manji M. Fagih M. Ajarim D. A modern regimen of pre-operative concurrent chemo-radiation therapy in locally advanced rectal cancer. [Clinical Trial, Phase II. Journal Article. Research Support, Non-U.S. Gov't] Journal of Surgical Oncology. 98(3):167-74, 2008 Sep 1.
  • Abubaker J. Bavi P. Al-Harbi S. Ibrahim M. Siraj AK. Al-Sanea N. Abduljabbar A. Ashari LH. Alhomoud S. Al-Dayel F. Uddin S. Al-Kuraya KS. Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population. Oncogene. 27(25):3539-45, 2008 Jun 5.
  • Uddin S. Ahmed M. Bavi P. El-Sayed R. Al-Sanea N. AbdulJabbar A. Ashari LH. Alhomoud S. Al-Dayel F. Hussain AR. Al-Kuraya KS. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer. Cancer Research. 68(9):3379-88, 2008 May 1.
  • Al-Saleh I. Arif J. El-Doush I. Al-Sanea N. Jabbar AA. Billedo G. Shinwari N. Mashhour A. Mohamed G. Carcinogen DNA adducts and the risk of colon cancer: case-control study.[Journal Article. Research Support, Non-U.S. Gov't] Biomarkers. 13(2):201-16, 2008 Mar.
  • Bavi PP. Abubaker JA. Jehan ZD. Al-Jomah NA. Siraj AK. Al-Harbi SR. Atizado VL. Abduljabbar AS. Alhomoud SJ. Ashari LH. Al-Dayel FH. Uddin S. Al-Kuraya KS. Alsanea NA. Colorectal carcinomas from Middle East. Molecular and tissue microarray analysis of genomic instability pathways.[see comment]. Saudi Medical Journal. 29(1):75-80, 2008 Jan.
  • Al-Kuraya K. Novotny H. Bavi P. Siraj AK. Uddin S. Ezzat A. Sanea NA. Al-Dayel F. Al-Mana H. Sheikh SS. Mirlacher M. Tapia C. Simon R. Sauter G. Terracciano L. Tornillo L. HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer. [Journal Article. Multicenter Study. Research Support, Non-U.S. Gov't] Journal of Clinical Pathology. 60(7):768-72, 2007 Jul.
  • Al-Khayal KA, Al-Omran MA. Computed tomography and ultrasonography in the diagnosis of equivocal acute appendicitis. A meta-analysis. Saudi Med J. 2007 Feb; 28(2):173-80. 
  • Zubaidi AM, Al Saghier M, Kabbani M, Abdo A. Colocutaneous fistula after mesh plug inguinal hernia repair- a delayed complication Ann Saudi Med. 2006 Sep-Oct;26(5):385-7.
  • Al-Sanea N. Isbister WH. Is palliative resection of the primary tumour, in the presence of advanced rectal cancer, a safe and useful technique for symptom control?. [Journal Article] ANZ Journal of Surgery. 74(4):229-32, 2004 Apr.
  • Isbister WH. Al-Sanea N. POSSUM: a re-evaluation in patients undergoing surgery for rectal cancer. The Physiological and Operative Severity Score for Enumeration of Mortality and Morbidity. ANZ Journal of Surgery. 72(6):421-5, 2002 Jun.
  • Al-Homoud SJ, Habib ZS, Abdul Jabbar AS, Isbister WH. Management of sacrococcygeal pilonidal disease. Saudi Med J. 2001 Sep; 22(9):762-4.
  • Isbister WH. Al Sanea N. The cutting seton: an experience at King Faisal Specialist Hospital. [Journal Article] Diseases of the Colon & Rectum. 44(5):722-7, 2001 May.
  • Abdujabbar AS, Perianal extramammary Paget's disease. Eur J Surg Oncol. 2000 Sep;26(6):612-4